St. Stamford Modern Cancer Hospital Guangzhou في العلاج المناعي مع Keytruda (Pembolizumab)

St. Stamford Modern Cancer Hospital Guangzhou is a specialized oncology facility established in 2005. The hospital operates 11 departments within a single building. It also maintains service centers in Kuala Lumpur and Penang. The facility is approved by the Ministry of Health of China.

Accreditations and Institutional Affiliations

The hospital has passed American JCI accreditation with high scores. This certification confirms adherence to international standards for patient safety and quality of care. The facility is also recognized by several professional organizations:

• Member of the International Union Against Cancer
• Member of the China Anti-Cancer Association (CACA)
• Registered unit of the Malaysia-China Anti-Cancer Association
• Cooperation unit with the Penang Anti-cancer Association

As a training base for Belt and Road Integrative Oncology, the hospital leads regional medical exchange programs.

Integrative Oncology and Minimally Invasive Surgery

The oncology department uses a multidisciplinary team (MDT) model. Specialists have around 20 years of experience. This team creates individualized plans combining Traditional Chinese Medicine (TCM) with Western therapies. Surgeons use small-incision techniques to target tumors directly while sparing healthy tissue.

The hospital reports success rates for interventional therapy based on cancer stage:

• Approximately 90% for Stage I (early stage)
• Between 85% and 70% for Stage IIA–IIB
• Approximately 52% to 48% for Stage IIIA–IIIB
• About 18% for Stage IV (late stage)

Dr. Wang Baoli and Dr. Zhang Fujun focus on targeted therapies. These include DEB-TACE, which uses drug-eluting beads to deliver high-concentration chemotherapy directly to tumor blood vessels. For localized radiation, the team uses iodine-125 particle implantation to treat tumors from the inside.

Traditional Chinese Medicine and Stem Cell Therapy

Integrative care includes specialized TCM delivery methods that support standard cancer treatments. Dr. Wu Qingkai has 40 years of experience. He and Dr. Yin Pingshan oversee these protocols. The hospital uses an inter-artery catheterization spray pump for continuous TCM infusion. Other methods include aerosol inhalation and acupoint injection therapy.

The hospital also provides autologous stem cell regeneration. This process involves four steps:

1. Collection of marrow from the patient
2. Isolation and purification of stem cells in a laboratory
3. Transfusion of the cell suspension back into the patient
4. Natural differentiation of cells to repair damaged tissues

This therapy treats conditions affecting nerves, organs, and tissues. It is also used for anti-aging purposes.

Diagnostic and Treatment Technologies

The hospital uses imaging-guided decision-making to stage cancers and monitor treatment. Diagnostic tools include PET-CT for detecting metastasis and CT-guided biopsies for precise tissue sampling. Specialized testing includes HPV testing for tongue base tumors and CEA marker monitoring for colorectal cancer.

For tumor destruction, the hospital uses several thermal and non-thermal technologies:

• Nanoknife – uses electric pulses to break down tumor cell membranes
• Cryotherapy – destroys tumor tissue through extreme freezing
• Microwave Ablation – uses heat to neutralize localized lesions
• Photon Knife – a three-dimensional directional radiation system

Specialists use these tools to treat over 30 cancer types, including nasopharyngeal, breast, and pancreatic malignancies.

Services for International Patients

The hospital treats many patients from Indonesia, Pakistan, and Mongolia. International visitors have access to interpreter and translator support throughout their stay. An airport drop-off service simplifies travel for departing patients. To support long-term recovery, the hospital runs a follow-up service with regular visits for both patients and their families.